Today: 12 May 2026
Analog Devices stock retreats from 52-week high despite Barclays upgrade ahead of earnings
12 February 2026
1 min read

Analog Devices stock retreats from 52-week high despite Barclays upgrade ahead of earnings

NEW YORK, Feb 12, 2026, 16:17 (EST) — Trading extended into after-hours

Analog Devices, Inc. (NASDAQ:ADI) slipped 1.7% to $331.38 by Thursday’s close, surrendering earlier gains after peaking at $343.69. This came despite Barclays upgrading its view on the analog chipmaker.

The retreat comes right after a 3.6% jump for ADI, which hit $337 and notched a fresh 52-week high just a day ago. Now, with shares having surged, attention is turning to next week’s results and what management will say about demand.

Barclays’ Tom O’Malley boosted his rating on Analog Devices, shifting it to Overweight from Equal Weight and bumping up the price target to $375, previously $315. O’Malley cited the company’s significant industrial customer base as the key factor. For reference, “overweight” signals his view that the stock will outperform its sector. TipRanks

O’Malley says the group is beginning to catch “the PMI inflection” — that’s the purchasing managers’ indexes, a favorite shortcut for investors tracking business activity. Barclays flagged a wrinkle: distributor stockpiles have settled down, but “company inventories remain historically high.” That’s still a drag on factory usage and margins. Barclays gave Microchip and ON Semiconductor Equal Weight ratings, setting price targets at $80 and $75. Investing.com

Tech stocks seesawed Thursday, with U.S. equities dropping after Cisco’s earnings rattled nerves over AI spending and disruption, Reuters reported. Inflation numbers still loomed, keeping investors on edge. “What sectors… can increase productivity from AI investments” versus “what industries are going to be disrupted” is the fight in the market right now, GuideStone Funds’ Jack Herr said. Reuters

Still, this upgrade is a wager on timing — and timing isn’t bulletproof. Should the industrial comeback falter, or inventories linger through spring, ADI’s next move probably hinges more on its own commentary than on any analyst outlooks.

Analog Devices plans to report its first-quarter fiscal 2026 results at 7:00 a.m. ET on Wednesday, Feb. 18, with a conference call slated for 10:00 a.m. ET that same morning, according to the company.

First up: the U.S. consumer price index for January lands Friday at 8:30 a.m. ET—Feb. 13. That one tends to jolt rate bets and usually stirs up rate-sensitive tech.

Up next for investors: the CPI lands Feb. 13, followed by ADI’s outlook and demand signals on Feb. 18. What they say about industrial orders and inventories could spell out whether Thursday’s move was just a breather or the opening act of a sharper drop.

Stock Market Today

  • Glencore Initiates $2.55B Oil Trading Securitization Amid Cerrejon Coal Mine Closure Pressure
    May 12, 2026, 4:52 PM EDT. Glencore has launched a $2.55 billion receivables securitization program for its oil and gas commodity trading business, partnering with six banks to convert trade credit into asset-backed funding. This move aims to enhance liquidity and risk management in a capital-intensive segment exposed to counterparty risk. Concurrently, the Colombian government is urging Glencore to negotiate the closure of the Cerrejon coal mine, signaling increasing regulatory pressure on its energy coal assets. These developments highlight a tension between Glencore's evolving finance-heavy oil and gas trading model and the long-term viability of coal operations under environmental scrutiny. Investors should monitor impacts on Glencore's financial flexibility, asset mix, and commodity exposure amid shifting policy landscapes and commodity cycles.

Latest article

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
BuzzFeed Stock Nearly Doubles as Byron Allen Deal Buys Time, Not a Clean Turnaround

BuzzFeed Stock Nearly Doubles as Byron Allen Deal Buys Time, Not a Clean Turnaround

12 May 2026
BuzzFeed shares jumped 97% to about $1.44 Tuesday after Byron Allen’s family office agreed to buy 40 million new shares at $3 each, securing 52% control. Only $20 million is due in cash at closing, with the rest as a five-year promissory note. BuzzFeed reported Q1 revenue down 12.4% to $31.6 million and a net loss of $15.1 million. The company warned of “substantial doubt” about its ability to continue operating.
Mastercard stock slips as fee fight resurfaces and CPI looms
Previous Story

Mastercard stock slips as fee fight resurfaces and CPI looms

Toast stock slides after earnings as 2026 outlook flags higher hardware costs
Next Story

Toast stock slides after earnings as 2026 outlook flags higher hardware costs

Go toTop